Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion type Assertion NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_head.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion wasGeneratedBy ECO_0000203 NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_provenance.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion wasDerivedFrom befree-20140225 NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_provenance.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion SIO_000772 9120722 NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_provenance.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion evidence source_evidence_literature NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_provenance.
- NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_assertion description "[However, since P16 mutations were found only in metastatic tumours, they may be important events in late phases of tumour progression and could represent useful markers of tumour aggressiveness in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP214319.RAdSvS1RdCykxaewRBtGkvtYd76YwX7u8vUPsBa_PS45o130_provenance.